Physician profile
Ryan Kennedy
NPI 1922238294
$17,599.59
in general payments reported to CMS, 2019-2025
14 companies · $11K in 2025
The $11K reported for 2025 was more than what 97% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.33 · 2020: $50.86 · 2021: $26.68 · 2023: $116 · 2024: $6,648 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,500 · Travel and Lodging: $2,231 · Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,500.00 |
| Travel and Lodging | $2,230.64 |
| Food and Beverage | $767.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,115.08 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $111.88 | 2024-2025 | Zerbaxa, Dificid, Recarbrio |
| Haemonetics Corporation | $50.86 | 2020 | |
| Csl Behring | $41.82 | 2023 | Kcentra |
| Aroa Biosurgery Incorporated | $39.26 | 2025 | |
| Kls-Martin L.P. | $38.64 | 2024 | |
| Abiomed | $34.10 | 2024 | Impella |
| Shionogi INC | $27.71 | 2023 | Fetroja |
| Octapharma USA, INC. | $26.68 | 2021 | |
| Kerecis Limited | $25.47 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Tandem Diabetes Care, INC. | $25.17 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Allergan, INC. | $24.33 | 2019 | |
| Kci USA, INC. | $20.64 | 2023 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Melinta Therapeutics, LLC | $17.95 | 2024 | Rezzayo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Kennedy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.